Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity
Cells · 2026
DOI: 10.3390/cells15030228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Kalpana Subedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Epigenesis, Genetic, Immune Tolerance, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, Henry Ford Health System.
Abstract (Originalsprache)
Regulatory T cells (Tregs) are central mediators of immune tolerance, yet within tumors they adopt specialized phenotypes that confer the potent suppression of anti-tumor immune responses. Emerging evidence indicates that this functional plasticity is not driven by genetic alterations but instead arises from dynamic and context-dependent epigenetic reprogramming. While individual epigenetic mechanisms controlling Treg development and stability have been described, how tumor-derived cues reshape Treg epigenetic states, how these programs differ across cancer types, and which features distinguish tumor-infiltrating Tregs from their peripheral counterparts remain incompletely understood. In this review, we synthesize recent advances in DNA methylation, histone modifications, chromatin accessibility, and non-coding RNA regulation that govern Treg identity and function with a particular emphasis on tumor-specific epigenetic adaptations. We highlight emerging epigenetic hallmarks of intratumoral Tregs, discuss unresolved mechanistic questions, and evaluate the therapeutic potential and limitations of targeting epigenetic pathways to selectively modulate Tregs in cancer. By integrating mechanistic, cancer-specific, and translational perspectives, this review aims to provide a conceptual framework for understanding how epigenetic regulation shapes Treg behavior in the tumor microenvironment and how it may be exploited for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI 48202, USA.
- Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI 48202, USA.
- Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
- Department of Medicine, Henry Ford Health, Detroit, MI 48202, USA.
- Henry Ford Health + Michigan State University Health Sciences, Detroit, MI 48202, USA.
ORCID-Profile: Nirmal Parajuli, Xzaviar Kaymar Solone, Jeffrey Cruz, Sahil Kapur, Qing-Sheng Mi, Li Zhou
Förderung
- NCI NIH HHS
- NIAMS NIH HHS
- Henry Ford Health System
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Henry Ford Immunology Program
Zitieren
APA
Subedi, K., Parajuli, N., Solone, X. K., Cruz, J., Kapur, S., Fang, D., Mi, Q. S., & Zhou, L. (2026). Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity. Cells. https://doi.org/10.3390/cells15030228
Vancouver
Subedi K, Parajuli N, Solone XK, Cruz J, Kapur S, Fang D, et al. Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity. Cells. 2026. doi:10.3390/cells15030228
BibTeX
@article{Subedi2026,
author = {Subedi, Kalpana and Parajuli, Nirmal and Solone, Xzaviar Kaymar and Cruz, Jeffrey and Kapur, Sahil and Fang, Deyu and Mi, Qing-Sheng and Zhou, Li},
title = {Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15030228}
}
EUVIMED